Quality Systems, Inc. (NASDAQ: QSII) announced today that its management plans to present its corporate story at the upcoming 24
Annual Piper Jaffray Healthcare Conference.
The conference, which will showcase approximately 250 public and private companies within the healthcare sector for institutional investors, is scheduled for Tuesday, November 27
, 2012 and Wednesday, November 28
, 2012 at the New York Palace Hotel in New York City. Quality Systems’ President and Chief Executive Officer Steven T. Plochocki is scheduled to participate in a 30-minute fireside chat (including Q&A) on Tuesday, November 27
, 2012 at 8:00 A.M. local time.
A webcast of Quality Systems’ audio presentation will be available on Tuesday, November 27
at the start of the presentation and can be viewed by accessing
. It will be archived for 90 days.
Piper Jaffray (NYSE: PJC) is a leading investment bank and asset management firm serving clients in the U.S. and internationally. Founded in 1895, the firm is headquartered in Minneapolis and has offices across the U.S. and in London, Hong Kong and Zurich.
About Quality Systems, Inc.
Quality Systems, Inc
. and its
subsidiary develop and market computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices and small hospitals. Visit
for additional information.
SAFE HARBOR PROVISIONS FOR FORWARD-LOOKING STATEMENTS
This news release may contain forward-looking statements within the meaning of the federal securities laws, including but not limited to, statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue and net income). Risks and uncertainties exist that may cause the results to differ materially from those set forth in these forward-looking statements. Factors that could cause the anticipated results to differ from those described in the forward-looking statements are set forth in Part I, Item A of our most recent Annual Report on Form 10-K for the fiscal year ended March 31, 2011, including but not limited to: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; seasonal patterns of sales and customer buying behavior; impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; and general economic conditions. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of a fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.